Clinical trial
SQ-Kyrin Transcatheter Mitral Valve Repair System Feasibility Study
NCT05040074 is registered in ClinicalTrials.gov with Shanghai Shenqi Medical Technology Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SQ-Kyrin Transcatheter Mitral Valve Repair System Feasibility Study
- Lead sponsor
- Shanghai Shenqi Medical Technology Co., Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2021
- Completion date
- October 31, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitral regurgitation